From Calcium-dependent currents to Multitarget Therapy: A Pharmacological Strategy for Glioblastoma

Glioblastoma (GBM) is an aggressive primary brain tumor with limited treatment options and substantial interpatient heterogeneity. Ion transport and cell-volume regulation may represent pharmacological vulnerabilities in glioma stem cells (GSCs). Here, we characterized membrane currents in patient-derived GSCs, identifying a calcium-dependent anion conductance consistent with volume-regulated anion channels (VRACs) and an inward current consistent with Na+/Ca++ exchanger exchanger (NCX) activity. Based on these findings, we investigated individual compounds and developed a multitarget cocktail comprising niflumic acid (NFA), bumetanide (BTN), and R-ketorolac (R-K) to target complementary mechanisms involved in ion homeostasis, cell-volume regulation, and cellular dynamics. The cocktail affected cell viability and mechanical properties and showed synergistic effects in U87 cells and patient-derived GSCs with similar electrophysiological profiles. Treatment did not measurably alter spontaneous activity in cultured hippocampal neurons but caused substantial HMC3 cytotoxicity. Encapsulation in transferrin-functionalized liposomes attenuated HMC3 toxicity while preserving activity against glioblastoma cells, suggesting a potential strategy to improve treatment selectivity. Further pharmacological studies identified a potential vulnerability associated with NCX activity, although its contribution to cytotoxicity remains unclear. Overall, our findings highlight electrophysiological heterogeneity in patient-derived GSCs and support further investigation of ion transport as a therapeutic target in GBM. Combining multitarget pharmacology with targeted drug delivery may help address heterogeneous treatment responses, although further studies are needed to establish the underlying mechanisms, safety, and vivo efficacy.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.16.765581
Primary Topic
Glioma Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

From Calcium-dependent currents to Multitarget Therapy: A Pharmacological Strategy for Glioblastoma

Ivana Manini, Tamara Ius, Cesar Adolfo Sánchez Triviño, Renza Spelat et al.
bioRxiv (Cold Spring Harbor Laboratory)
Glioma Diagnosis and Treatment
preprint

From Calcium-dependent currents to Multitarget Therapy: A Pharmacological Strategy for Glioblastoma

Ivana Manini, Tamara Ius, Cesar Adolfo Sánchez Triviño, Renza Spelat, Alessia Norbedo, Miran Škrap, Licio Collavin, Elena Rampazzo, Luca Persano, Vincent Torre, Daniela Cesselli, Loredana Casalis, Anna Menini, Pietro Parisse, Alice Scomparin
preprint en

Abstract

Glioblastoma (GBM) is an aggressive primary brain tumor with limited treatment options and substantial interpatient heterogeneity. Ion transport and cell-volume regulation may represent pharmacological vulnerabilities in glioma stem cells (GSCs). Here, we characterized membrane currents in patient-derived GSCs, identifying a calcium-dependent anion conductance consistent with volume-regulated anion channels (VRACs) and an inward current consistent with Na+/Ca++ exchanger exchanger (NCX) activity. Based on these findings, we investigated individual compounds and developed a multitarget cocktail comprising niflumic acid (NFA), bumetanide (BTN), and R-ketorolac (R-K) to target complementary mechanisms involved in ion homeostasis, cell-volume regulation, and cellular dynamics. The cocktail affected cell viability and mechanical properties and showed synergistic effects in U87 cells and patient-derived GSCs with similar electrophysiological profiles. Treatment did not measurably alter spontaneous activity in cultured hippocampal neurons but caused substantial HMC3 cytotoxicity. Encapsulation in transferrin-functionalized liposomes attenuated HMC3 toxicity while preserving activity against glioblastoma cells, suggesting a potential strategy to improve treatment selectivity. Further pharmacological studies identified a potential vulnerability associated with NCX activity, although its contribution to cytotoxicity remains unclear. Overall, our findings highlight electrophysiological heterogeneity in patient-derived GSCs and support further investigation of ion transport as a therapeutic target in GBM. Combining multitarget pharmacology with targeted drug delivery may help address heterogeneous treatment responses, although further studies are needed to establish the underlying mechanisms, safety, and vivo efficacy.

bioRxiv (Cold Spring Harbor Laboratory)
University of Udine (IT), Scuola Internazionale Superiore di Studi Avanzati (IT), University of Trieste (IT), AREA Science Park (IT), Elettra-Sincrotrone Trieste S.C.p.A. (IT), Istituto Officina dei Materiali (IT), Città della Speranza Foundation (IT)
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon